Multicenter Study on the Safety and Efficacy of First-Line Nivolumab-Combination Chemotherapy in Patients Aged 75 Years and Older with Unresectable Advanced or Recurrent Gastric Cancer

Oncology (Switzerland) · Published 2026-01-12 · DOI 10.1159/000550345

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000550345

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Association of Hypoglycemic Agents with the Risk of Platinum-Based Chemotherapy-Induced Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus · Oncology (Switzerland) · 2026 · Same journal
• Prognostic Effect of Preoperative Albumin-to-Globulin Ratio in Patients with Non-Metastatic Bladder Cancer Undergoing Radical Cystectomy · Oncology (Switzerland) · 2026 · Same journal
• The Initial Therapeutic Response in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Contributes to the Change of Liver Function during Treatment: A Multicenter Analysis · Oncology (Switzerland) · 2026 · Same journal
• Sex Differences in Cardiotoxicity of Anaplastic Lymphoma Kinase Inhibitors: An Analysis of the FDA Adverse Event Reporting System · Oncology (Switzerland) · 2025 · Same journal
• Weight Variations during First-Line Systemic Treatment of Metastatic Non-Small Cell Lung Cancer: New Paradigms from Real-World Data · Oncology (Switzerland) · 2026 · Same journal
• Evolving Therapeutic Landscape in Non–Muscle-Invasive Bladder Cancer (NMIBC) · Oncology (Switzerland) · 2026 · Same journal
• Lymphatic Metastasis Predicts Better Response to Nivolumab in Recurrent or Metastatic Gastric Cancer: Insights from Tumor-Draining Lymph Node Immunity and Long-Term Outcomes · Oncology (Switzerland) · 2025 · Same journal
• Emergency Department Visits After Radiotherapy in Patients with Solid Malignancies: Analysis of Causality and Severity · Oncology (Switzerland) · 2026 · Same journal
• Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases · Oncology (Switzerland) · 2025 · Same journal
• Safety and Treatment Continuity of Switching between CDK4/6 Inhibitors for Metastatic Breast Cancer due to Adverse Events: An Exploratory Single-Center Study in Japan · Oncology (Switzerland) · 2025 · Same journal